Numerate

Numerate is a privately held biotechnology company applying novel machine learning algorithms at cloud scale to address key challenges in small molecule drug discovery. Numerate's drug design platform combines advances in computer science and statistics with traditional medicinal chemistry approaches, while tackling the factors that determine the success or failure of drug candidates. Numerate is using this proprietary platform to develop a range of therapeutic programs in the cardiovascular, metabolic, and neurodegenerative disease areas, focusing on issues that computer-aided drug discovery typically does not solve.